Urol. praxi, 2011; 12(5): 313-314

Hormonal therapy and low risk prostate cancer?

MUDr.David Hradil, MUDr.Milan Král, Ph.D., MUDr.Igor Hartmann, doc.MUDr.Vladimír Študent, Ph.D.
Urologická klinika LF UP a FN Olomouc

The author presents a case of patient with low risk prostate cancer, who underwent atypicly combination therapy (hormonal therapy

and planned currative radiotherapy). We mention possibilities of treatment according to the last version of EAU Guidelines 2010.

Keywords: low risk localised prostate cancer, hormonal treatment

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hradil D, Král M, Hartmann I, Študent V. Hormonal therapy and low risk prostate cancer? Urol. praxi. 2011;12(5):313-314.
Download citation

References

  1. Heidenreich A, Bolla M, Joniau S, Mason MD, Matveev V, Mottet N, Schmid H-P, van der Kwast TH, Wiegel T, Zattoni F. EAU Guidelines, April 2010, Prostate cancer: 37-38, 47-48, 63-64, 111.
  2. Král M, Študent V, Hrabec M. Predikční nomogramy u karcinomu prostaty. Urol. praxi, 2008; 9(1): 33-36.
  3. http://urology.jhu.edu/prostate/partintables.php.
  4. http://urology.jhu.edu/prostate/hanTables.php.
  5. Jansa J, Petera J. Hormonální léčba karcinomu prostaty. Urol. praxi, 2009; 10(6): 336-338.
  6. Stálahová V. Primární hormonální léčba lokalizovaného karcinomu prostaty. Urol. praxi, 2009; 10(4): 215-217.
  7. Vik V, Zachoval R, Klement V, Záleský M. Nová doporučení hormonální léčby karcinomu prostaty v kombinace s radioterapií. Urol. praxi, 2007; 8(5): 218-221.
  8. Král M, Študent V, Kurfürstová D, Vidlář A, Kučerová L. Gleasonovo skore v biopsii a po radikální prostatektomii - změny po konferenci ISUP 2005 a význam pro urologa. Urol. Praxi, 2007; 8(4): 173-178.
  9. Doležal J, Tvarůžek J, Staník M, Zachoval R, Šimoník I, Korsa M, Vagunda V. Časné zkušenosti s roboticky asistovanou laparoskopickou radikální prostatektomií - prvních 153 pacientů. Ces Urol 2009; 13(2): 168-177.
  10. NCCN Clinical Practice Guidelines in Oncology TM, Prostate Cancer, V.I. 2008, www.nccn.org.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.